The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((R)-Carbamoylphenylmethyl)-N-((R)-1-phenylethyl)benzamide ID: ALA4786793
PubChem CID: 118246720
Max Phase: Preclinical
Molecular Formula: C23H22N2O2
Molecular Weight: 358.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](c1ccccc1)N(C(=O)c1ccccc1)[C@@H](C(N)=O)c1ccccc1
Standard InChI: InChI=1S/C23H22N2O2/c1-17(18-11-5-2-6-12-18)25(23(27)20-15-9-4-10-16-20)21(22(24)26)19-13-7-3-8-14-19/h2-17,21H,1H3,(H2,24,26)/t17-,21-/m1/s1
Standard InChI Key: YFQRFEAYDFPJMW-DYESRHJHSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
43.0745 -1.3454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0733 -2.1691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7855 -2.5822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4993 -2.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4965 -1.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7837 -0.9366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.7853 -3.4035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0734 -3.8119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.4970 -3.8123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2090 -3.4039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.4968 -4.6336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.3616 -3.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6497 -3.8116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9412 -3.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2339 -3.8071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.2332 -4.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9458 -5.0421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6543 -4.6279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3618 -2.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0732 -4.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3612 -5.0458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.6537 -5.2127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.4407 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0164 -6.5790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.8079 -6.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0165 -5.5719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4393 -5.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 3 1 6
7 8 1 0
7 9 1 0
9 10 1 0
9 11 2 0
8 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
12 19 1 1
8 20 1 0
20 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.44Molecular Weight (Monoisotopic): 358.1681AlogP: 4.12#Rotatable Bonds: 6Polar Surface Area: 63.40Molecular Species: NEUTRALHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.02CX LogD: 4.02Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.72Np Likeness Score: -0.81
References 1. Kobayashi JI,Hirasawa H,Fujimori Y,Nakanishi O,Kamada N,Ikeda T,Yamamoto A,Kanbe H. (2021) Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects., 30 [PMID:33333445 ] [10.1016/j.bmc.2020.115903 ]